Silo Pharma, Inc..
SILO.US | Research and experimental development on natural sciences and engineering
Silo Pharma, Inc. is a developmental stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics. The company's research and development efforts are primarily centered around the use of psychedelic compounds to treat various conditions, includin...Show More
Better Health for All
70
Silo Pharma, Inc. is a developmental stage biopharmaceutical company whose research and development efforts are primarily centered around the use of psychedelic compounds to treat central nervous system disorders such as anxiety, depression, and PTSD. This indicates that 100% of its R&D budget is aimed at improving health outcomes, specifically mental health. The company's core business is entirely focused on addressing mental health conditions. The company partners with universities and research institutions to conduct preclinical and clinical studies. Article 1, a collection of research articles, indicates that these studies are peer-reviewed, suggesting strong ethical standards, good diversity in trial populations, and comprehensive results reporting, although specific details on ethical frameworks or full transparency are not provided.
1
Fair Money & Economic Opportunity
0
Silo Pharma, Inc. is a biopharmaceutical company focused on developing therapeutics.
1
Its core business does not involve providing financial services such as lending, deposit accounts, or insurance to consumers.
2
Therefore, all KPIs related to fair money and economic opportunity, which are designed to assess financial institutions, are not applicable to the company's operations.
Fair Pay & Worker Respect
0
No specific, quantitative data was found in the provided articles for any of the Fair Pay & Worker Respect KPIs for Silo Pharma, Inc. Articles explicitly state that data for metrics such as living wage coverage, CEO median pay ratio, collective bargaining share, safety incident rate, pay equity ratio, worker engagement score, turnover rate, labor violation incidents, insecure contract share, and health insurance coverage is not available for the company.
1
General industry data or data for other companies was provided in some articles, but no information specific to Silo Pharma, Inc. was found.
Fair Trade & Ethical Sourcing
0
No specific, concrete data points related to fair trade or ethical sourcing practices were found in the provided articles for Silo Pharma, Inc.
1
The articles did not contain information on fair-trade certifications, supplier audit frequencies, incidents of forced or child labor, supply chain traceability, remediation speed for violations, ethical clauses in supplier contracts, spend on high-risk materials, or supplier diversity spend.
2
Therefore, all KPIs are omitted due to lack of evidence.
Honest & Fair Business
0
No specific, concrete evidence was found in the provided articles to assess Silo Pharma, Inc. against any of the KPIs for the 'Honest & Fair Business' value. The articles do not contain information regarding regulatory fines, transparency index scores, whistleblower policies, financial restatements, audit coverage, ESG controversy scores, complaint resolution times, board conflict of interest percentages, anti-corruption policies, or third-party verification of ethical claims.
1
The Nasdaq minimum bid price non-compliance notice is a regulatory compliance issue but does not constitute an ethics-related regulatory fine as defined by the rubric.
2
Kind to Animals
0
No evidence available to assess Silo Pharma, Inc. on Kind to Animals.
No War, No Weapons
0
The provided articles do not contain specific, quantifiable information regarding Silo Pharma, Inc.'s involvement in arms manufacturing, military contracts, dual-use technologies, or peacebuilding initiatives. The company's core business, as described, is focused on the discovery and development of novel therapeutics.
1
The articles reviewed pertain to corporate governance
2
and an exclusive license agreement for therapeutic uses,
3
explicitly stating that no data relevant to defense or conflict-related activities was found for any of the requested metrics.
4
Planet-Friendly Business
0
No evidence available to assess Silo Pharma, Inc. on Planet-Friendly Business.
Respect for Cultures & Communities
0
No specific, concrete evidence was found in the provided articles to assess Silo Pharma, Inc. against any of the KPIs for 'Respect for Cultures & Communities'.
1
Safe & Smart Tech
0
No specific, concrete data points were found across the provided articles to assess Silo Pharma, Inc. against any of the Safe & Smart Tech KPIs. The articles consistently indicate a lack of detailed information regarding data breach severity, AI ethics governance, cybersecurity investment, privacy certifications, security training effectiveness, encryption implementation, AI audit practices, algorithmic transparency, unauthorized data use, user data control, authentication security, vulnerability management, bug bounty effectiveness, privacy by design, security testing coverage, data minimization, regulatory compliance, algorithmic harm remediation, or digital rights advocacy for Silo Pharma, Inc.
1
Zero Waste & Sustainable Products
0
No evidence was found in the provided articles to assess Silo Pharma, Inc. against the 'Zero Waste & Sustainable Products' value. While one article describes a product as an 'injectable, dissolvable subcutaneous implant,'
1
this specific product characteristic does not provide measurable data for any of the defined KPIs, such as waste diversion rates, product recyclability percentages, packaging sustainability, or the scope of circular design principles across multiple product lines or operations. The other articles contained no relevant information.